Henrik Lawaetz

Chief Tech/Sci/R&D Officer at

StemCare A/S

71 year

76 connections

Health Technology

Commercial Services

Consumer Services

Profile

Henrik Lawaetz is currently the Medical Director at StemCare A. Previously, he was the Chief Executive Officer at Center For Clinical & Basic Research from 1995 to 1999, and a Partner & Managing Director at Scandinavian Life Science Invest ApS from 2000 to 2012.
He also held various director positions at Pharmacia AB, Exiqon A, Sophion Bioscience A, Nuevolution AB, Action Pharma A, Independent Pharmaceutica AB, Novo Nordisk Scandinavia AB, Demetech AB, and Biopheresis GmbH.
Additionally, he was the Co-Chairman at Sanos Bioscience A in 2010-2011.
Dr. Lawaetz holds a doctorate degree from The University of Wales and the University of Copenhagen, and an MBA from the Scandinavian International Management Institute.

Henrik Lawaetz active positions

Companies	Position	Start
StemCare A/S StemCare A/S BiotechnologyHealth Technology Stores stem cells from umbilical cord blood	Chief Tech/Sci/R&D Officer	-

All active positions of Henrik Lawaetz

Former positions of Henrik Lawaetz

Companies	Position	End
Scandinavian Life Science Invest ApS Scandinavian Life Science Invest ApS Investment ManagersFinance Scandinavian Life Science Invest's investment strategy aims to maximize return on investments. They are active investors in growth firms in the life science sector primarily in the areas of pharmaceutical development, biotechnology and medical technology. They generally take stakes from 10% to 49% in each firm, seeking to influence but not through a controlling interest. They invest in small and mid-sized life science firms primarily in Scandinavia and Europe. They seek long-term capital growth by constructing diversified portfolios through sector, firm size, development stage and financial status. They provide a combination of capital, industrial and financial expertise to their portfolio firms. Scandinavian Life Science Invest prefers to invest in phases after seed capital but before IPO. They look for firms with a strong patent position, clear market potential, proven medical need for the product or technology, expert science and scientific teams and incentives for key employees. The firm's exit strategies include trade sales, IPO and M&A.	Chief Investment Officer	31/12/2011
Sanos Bioscience A/S Sanos Bioscience A/S Pharmaceuticals: MajorHealth Technology Develops treatments for osteoporosis and other skeletal wasting diseases	Chairman	31/08/2009
Center For Clinical & Basic Research Center For Clinical & Basic Research Miscellaneous Commercial ServicesCommercial Services Provides radiology services	Chief Executive Officer	31/12/1998
Novo Nordisk Scandinavia AB Novo Nordisk Scandinavia AB Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets pharmaceutical products and services	Director/Board Member	-
Pharmacia AB Pharmacia AB Pharmaceuticals: MajorHealth Technology Pharmaceutical concern	Director/Board Member	-

See the detail of Henrik Lawaetz's experience

Training of Henrik Lawaetz

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Henrik Lawaetz's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	17
Pharmacia AB Pharmacia AB Pharmaceuticals: MajorHealth Technology Pharmaceutical concern	Health Technology
Exiqon A/S Exiqon A/S Miscellaneous Commercial ServicesCommercial Services Engages in the pharmaceutical industry	Commercial Services
The University of Wales The University of Wales Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
University of Copenhagen University of Copenhagen Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Scandinavian International Management Institute Scandinavian International Management Institute Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Scandinavian Life Science Invest ApS Scandinavian Life Science Invest ApS Investment ManagersFinance Scandinavian Life Science Invest's investment strategy aims to maximize return on investments. They are active investors in growth firms in the life science sector primarily in the areas of pharmaceutical development, biotechnology and medical technology. They generally take stakes from 10% to 49% in each firm, seeking to influence but not through a controlling interest. They invest in small and mid-sized life science firms primarily in Scandinavia and Europe. They seek long-term capital growth by constructing diversified portfolios through sector, firm size, development stage and financial status. They provide a combination of capital, industrial and financial expertise to their portfolio firms. Scandinavian Life Science Invest prefers to invest in phases after seed capital but before IPO. They look for firms with a strong patent position, clear market potential, proven medical need for the product or technology, expert science and scientific teams and incentives for key employees. The firm's exit strategies include trade sales, IPO and M&A.	Finance
Center For Clinical & Basic Research Center For Clinical & Basic Research Miscellaneous Commercial ServicesCommercial Services Provides radiology services	Commercial Services
Sophion Bioscience A/S Sophion Bioscience A/S Medical SpecialtiesHealth Technology Develops, manufactures and markets instruments and supplies automated patch clamping	Health Technology
Nuevolution AB Nuevolution AB Pharmaceuticals: MajorHealth Technology Provides biopharmaceutical products for treatment of oncology and chronic inflammatory diseases	Health Technology
Sanos Bioscience A/S Sanos Bioscience A/S Pharmaceuticals: MajorHealth Technology Develops treatments for osteoporosis and other skeletal wasting diseases	Health Technology
Action Pharma A/S Action Pharma A/S BiotechnologyHealth Technology Manufactures biopharmaceutical products	Health Technology
StemCare A/S StemCare A/S BiotechnologyHealth Technology Stores stem cells from umbilical cord blood	Health Technology
Biopheresis GmbH Biopheresis GmbH Miscellaneous Commercial ServicesCommercial Services Provides cancer treatments	Commercial Services
Independent Pharmaceutica AB Independent Pharmaceutica AB Medical DistributorsDistribution Services Provides pharmacological solutions for treatment of nicotine addiction.	Distribution Services
Wntresearch AB Wntresearch AB Pharmaceuticals: OtherHealth Technology Develops novel anti-metastatic therapies based synthetic peptides	Health Technology
Novo Nordisk Scandinavia AB Novo Nordisk Scandinavia AB Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets pharmaceutical products and services	Health Technology
Demetech AB